Notably, given the homology between glucocorticoid receptors and progesterone receptors and the potential risk of inducing abortion and amenorrhea in females, current GR antagonists may benefit from the further development of receptor selection (Schatzberg and Lindley, 2008). The gene discussed is PGR; the disease is amenorrhea.